Supplements

Pacing supplement: Introduction

October 2018

Pacing supplement: Introduction

This supplement is published to mark 60 years of cardiac pacing, with a particular focus on the history and developments of pacing in the UK....
Pacing supplement: Current and future perspectives on cardiac pacing

October 2018 Br J Cardiol 2018;25(suppl 3):S4–S7

Pacing supplement: Current and future perspectives on cardiac pacing

Cardiac pacing is 60 years old and is in continuous development. In this article, I review current pacing practice aimed at improving training by using...
Pacing supplement: Early days of pacing in the UK – the British contribution to the field of pacing

October 2018 Br J Cardiol 2018;25(suppl 3):S7–S10

Pacing supplement: Early days of pacing in the UK – the British contribution to the field of pacing

This paper reviews some of the early experiences and difficulties of pacing (a field in its infancy at the time) at St. George’s Hospital, London,...
Pacing supplement: Cardiac resynchronisation therapy – developments in heart failure management

October 2018 Br J Cardiol 2018;25(suppl 3):S12–S19

Pacing supplement: Cardiac resynchronisation therapy – developments in heart failure management

Cardiac resynchronisation therapy (CRT) is a very effective treatment for selected patients with severe and mild heart failure (HF), impaired left ventricular (LV) function and...
Pacing supplement: Drugs with devices in the management of heart failure

October 2018 Br J Cardiol 2018;25(suppl 3):S20–S24

Pacing supplement: Drugs with devices in the management of heart failure

Cardiac device therapy has changed the landscape of heart failure management in the past decade in patients with heart failure and reduced left ventricular ejection...
Pacing supplement: His-bundle pacing – UK experience and HOPE for the future

October 2018 Br J Cardiol 2018;25(suppl 3):S25–S29

Pacing supplement: His-bundle pacing – UK experience and HOPE for the future

Permanent His-bundle pacing promises to be a major advance in the field of cardiac rhythm management. It allows ventricular stimulation to occur via the hearts’...
Pacing supplement: Techniques in pacemaker and defibrillator lead extraction

October 2018 Br J Cardiol 2018;25(suppl 3):S35–S39

Pacing supplement: Techniques in pacemaker and defibrillator lead extraction

Transvenous lead extraction is the gold standard for cardiovascular implantable electronic device lead removal. Increasing rates of device implantation have led to an increased number...
Pacing supplement: Leadless pacing

October 2018 Br J Cardiol 2018;25(suppl 3):S30–S34

Pacing supplement: Leadless pacing

Conventional lead-based pacing has developed over 60 years, but is associated with complications related to the generator and leads. Leadless pacing has evolved over the...
Pacing supplement: Remote monitoring

October 2018 Br J Cardiol 2018;25(suppl 3):S40–S43

Pacing supplement: Remote monitoring

Remote monitoring embraces data collection, data analysis, clinical decision-making and an effector arm that provides therapy instructions to the patient, or their carer or a...
Pacing supplement: Remote follow-up of implantable cardiac devices – a physiologist’s experience

October 2018 Br J Cardiol 2018;25(suppl 3):S44–S45

Pacing supplement: Remote follow-up of implantable cardiac devices – a physiologist’s experience

The advancement of remote or mobile technologies over the last 15 years has changed our lives beyond all comprehension. The evolution of the remote monitoring...
Introduction

September 2018 Br J Cardiol 2018;25(suppl 2):S3

Introduction

Click here to take a CPD test on this supplement It is estimated that there are well over four million people living with type 2 diabetes in the...
The cardiovascular profile in diabetes

September 2018 Br J Cardiol 2018;25(suppl 2):S4–S7

The cardiovascular profile in diabetes

Click here to take a CPD test on this article Diabetes mellitus imposes considerable premature vascular risks on individuals. In this short review, the well-established concept...
Diabetes and cardiovascular risk in UK South Asians: an overview

September 2018 Br J Cardiol 2018;25(suppl 2):S8–S13

Diabetes and cardiovascular risk in UK South Asians: an overview

Click here to take a CPD test on this article Diabetes affects at least 415 million people worldwide, this epidemic disproportionately affects certain ethnicities, like South...
Drugs for diabetes: the cardiovascular evidence base

September 2018 Br J Cardiol 2018;25(suppl 2):S14–S18

Drugs for diabetes: the cardiovascular evidence base

Click here to take a CPD test on this article Cardiovascular (CV) disease is a cause of significant morbidity and mortality in patients with type 2...
Optimising cardiovascular risk reduction in diabetes

September 2018 Br J Cardiol 2018;25(suppl 2):S19–S26

Optimising cardiovascular risk reduction in diabetes

Click here to take a CPD test on this article Over the last few years, there has been a growing interest in the role of antihyperglycaemic...
Introduction

August 2018 Br J Cardiol 2018;25(suppl 1):S3–S5

Introduction

Patients with atrial fibrillation are at an increased risk for ischaemic stroke and require long-term prophylaxis with an anticoagulant. Ablation and direct current cardioversion are...
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI

August 2018 Br J Cardiol 2018;25(suppl 1):S6–S11

Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI

The PIONEER AF-PCI trial was an open-label, randomised, controlled, multi-centre trial that evaluated the safety of two different regimens of rivaroxaban compared with vitamin K...
The PIONEER AF-PCI study: its implications for everyday practice in the UK

August 2018 Br J Cardiol 2018;25(suppl 1):S12–S15

The PIONEER AF-PCI study: its implications for everyday practice in the UK

Our ageing population is resulting in increasing rates of coronary artery disease and atrial fibrillation (AF), which require intervention. Anticoagulation in patients with non-valvular AF...
The potential for NOACs in cardiac ablation in the UK

August 2018 Br J Cardiol 2018;25(suppl 1):S16–S17

The potential for NOACs in cardiac ablation in the UK

The procedural and post-procedure risk of stroke associated with catheter ablation of atrial fibrillation (AF), even in patients with low CHA2DS2-VASc scores, highlight the need...
Use of NOAC drugs in DC cardioversion for patients with non-valvular AF

August 2018 Br J Cardiol 2018;25(suppl 1):S18–S20

Use of NOAC drugs in DC cardioversion for patients with non-valvular AF

Direct current cardioversion (DCCV) is a frequently used and effective strategy for the restoration of sinus rhythm in patients with atrial fibrillation (AF). Anticoagulation for...